1. Home
  2. OVLY vs HUMA Comparison

OVLY vs HUMA Comparison

Compare OVLY & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

N/A

Current Price

$32.90

Market Cap

269.7M

Sector

Finance

ML Signal

N/A

Logo Humacyte Inc.

HUMA

Humacyte Inc.

N/A

Current Price

$1.23

Market Cap

182.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVLY
HUMA
Founded
1990
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
182.6M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
OVLY
HUMA
Price
$32.90
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.00
AVG Volume (30 Days)
15.7K
5.9M
Earning Date
04-27-2026
01-01-0001
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
2.12
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$731.05
P/E Ratio
$15.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.70
$0.88
52 Week High
$34.16
$3.35

Technical Indicators

Market Signals
Indicator
OVLY
HUMA
Relative Strength Index (RSI) 53.19 58.14
Support Level $32.81 $0.92
Resistance Level $34.08 $1.26
Average True Range (ATR) 0.71 0.09
MACD -0.13 0.01
Stochastic Oscillator 51.55 68.52

Price Performance

Historical Comparison
OVLY
HUMA

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: